Clinical Trial: A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Atopic Dermatitis
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Clinical Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 Ointment in Adult Subjects With Atopic Dermatitis
Brief Summary:
Phase 2 clinical trial conducted in 2 parts: Part 1 - Pharmacokinetics and Part 2 - Randomized and Placebo Controlled (subject and clinical assessors will be blinded).Study Product will be applied to AD BID days 1-28.There will be weekly visits from Baseline (day 1) through Day 29.There is a final follow up visit 2 weeks after.
Read more